CLINICAL_TRIALS
trial_result
· 2018-03-19
Clinical Trial Update: Study to Evaluate the Clinical Efficacy of Streptococcus Dentisani CECT 7746 in Caries Risk Reduction [Phase 1]
Summary
Phase 1 trial evaluating the probiotic Streptococcus dentisani CECT 7746 for reduction of caries risk has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AB Biotics, SA | Conditions: Caries | Phase 1 | Status: COMPLETED